$CREX
CREATIVE REALITIES, INC. Stock $crex

$crex Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000143774923022050 Filed on August 04, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$11.57M	$9.196M
YoY Change	3.47%	-15.81%
Cost Of Revenue	$6.265M	$4.898M
YoY Change	-6.02%	-21.77%
Gross Profit	$5.303M	$4.298M
YoY Change	17.48%	-7.81%
Gross Profit Margin	45.84%	46.74%
Selling, General & Admin	$3.933M	$3.824M
YoY Change	12.15%	3.1%
% of Gross Profit	74.17%	88.97%
Research & Development	$393.0K	$377.0K
YoY Change	65.13%	-9.81%
% of Gross Profit	7.41%	8.77%
Depreciation & Amortization	$813.0K	$797.0K
YoY Change	-8.14%	70.3%
% of Gross Profit	15.33%	18.54%
Operating Expenses	$5.143M	$4.998M
YoY Change	7.19%	7.9%
Operating Profit	$160.0K	-$700.0K
YoY Change	-156.34%	-2433.33%
Interest Expense	$734.0K	$787.0K
YoY Change	-3.04%	4.93%
% of Operating Profit	458.75%
Other Income/Expense, Net	-$2.106M	-$680.0K
YoY Change	652.14%	-152.92%
Pretax Income	-$1.946M	-$1.380M
YoY Change	245.04%	-204.94%
Income Tax	-$15.00K	$45.00K
% Of Pretax Income
Net Earnings	-$1.931M	-$1.425M
YoY Change	248.56%	-212.92%
Net Earnings / Revenue	-16.69%	-15.5%
Basic Earnings Per Share	-$0.22	-$0.19
Diluted Earnings Per Share	-$0.22	-$0.19
COMMON SHARES
Basic Shares Outstanding	7.409M	7.409M
Diluted Shares Outstanding	8.713M	7.406M

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.376M	$3.264M
YoY Change	922.71%	14.93%
Cash & Equivalents	$8.376M	$3.264M
Short-Term Investments
Other Short-Term Assets	$960.0K	$784.0K
YoY Change	-40.67%	-74.8%
Inventory	$2.306M	$1.148M
Prepaid Expenses
Receivables	$5.865M	$6.496M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$17.51M	$11.69M
YoY Change	35.19%	-32.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$513.0K	$453.0K
YoY Change	165.8%	223.57%
Goodwill	$26.45M	$26.45M
YoY Change	1.38%	1.38%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$43.00K	$44.00K
YoY Change	126.32%	158.82%
Total Long-Term Assets	$52.18M	$52.24M
YoY Change	0.81%	1.79%
TOTAL ASSETS
Total Short-Term Assets	$17.51M	$11.69M
Total Long-Term Assets	$52.18M	$52.24M
Total Assets	$69.69M	$63.93M
YoY Change	7.69%	-6.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.340M	$2.892M
YoY Change	9.87%	-42.7%
Accrued Expenses	$4.499M	$3.217M
YoY Change	48.53%	20.4%
Deferred Revenue	$3.507M	$2.827M
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change	-100.0%
Long-Term Debt Due	$4.211M	$4.197M
YoY Change	136.97%	100.91%
Total Short-Term Liabilities	$19.66M	$17.76M
YoY Change	46.34%	7.37%
LONG-TERM LIABILITIES
Long-Term Debt	$10.57M	$11.59M
YoY Change	-20.81%	-13.47%
Other Long-Term Liabilities	$175.0K	$136.0K
YoY Change	-98.48%	-98.88%
Total Long-Term Liabilities	$10.75M	$11.72M
YoY Change	-56.79%	-54.1%
TOTAL LIABILITIES
Total Short-Term Liabilities	$19.66M	$17.76M
Total Long-Term Liabilities	$10.75M	$11.72M
Total Liabilities	$42.29M	$40.08M
YoY Change	10.38%	-4.76%
SHAREHOLDERS EQUITY
Retained Earnings	-$54.77M	-$52.83M
YoY Change	11.59%	8.89%
Common Stock	$104.0K	$74.00K
YoY Change	-52.07%	-65.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$27.40M	$23.86M
YoY Change
Total Liabilities & Shareholders Equity	$69.69M	$63.93M
YoY Change	7.69%	-6.69%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$1.931M	-$1.425M
YoY Change	248.56%	-212.92%
Depreciation, Depletion And Amortization	$813.0K	$797.0K
YoY Change	-8.14%	70.3%
Cash From Operating Activities	$1.966M	$2.476M
YoY Change	-299.19%	-295.89%
INVESTING ACTIVITIES
Capital Expenditures	$938.0K	$1.169M
YoY Change	-229.92%	-174.22%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$938.0K	-$1.169M
YoY Change	29.92%	-25.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.085M	-1.948M
YoY Change	-1409.29%	534.53%
NET CHANGE
Cash From Operating Activities	1.966M	2.476M
Cash From Investing Activities	-938.0K	-1.169M
Cash From Financing Activities	4.085M	-1.948M
Net Change In Cash	5.113M	-641.0K
YoY Change	-352.99%	-79.64%
FREE CASH FLOW
Cash From Operating Activities	$1.966M	$2.476M
Capital Expenditures	$938.0K	$1.169M
Free Cash Flow	$1.028M	$1.307M
YoY Change	-487.92%	320.26%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	66666000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	66666000
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7409000
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7409000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7266000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7266000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-33169
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MN
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-1967918
	dei	Entity Address Address Line1 EntityAddressAddressLine1	13100 Magisterial Drive, Suite 100
	dei	Entity Address City Or Town EntityAddressCityOrTown	Louisville
	dei	Entity Address State Or Province EntityAddressStateOrProvince	KY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	40223
	dei	City Area Code CityAreaCode	502
	dei	Local Phone Number LocalPhoneNumber	791-8800
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7409027
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3264000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1633000	usd
CY2023Q2	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	6496000	usd
CY2022Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	8263000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	1148000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2267000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	784000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1819000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	11692000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	13982000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	453000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	201000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1356000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1584000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	23936000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	23752000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	26453000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	26453000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	44000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	43000	usd
CY2023Q2	us-gaap	Assets Assets	63934000	usd
CY2022Q4	us-gaap	Assets Assets	66015000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2892000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3757000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3217000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3828000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2827000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1223000	usd
CY2023Q2	crex	Customer Deposit Current CustomerDepositCurrent	3985000	usd
CY2022Q4	crex	Customer Deposit Current CustomerDepositCurrent	2478000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	645000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	711000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	17763000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16496000	usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	208000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	711000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	873000	usd
CY2023Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	9881000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	9789000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	136000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	205000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	40076000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	40436000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	74000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	72000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	76618000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	75916000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-52834000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-50409000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	23858000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	25579000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	63934000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	66015000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9196000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	10923000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	19140000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	21680000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4898000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6261000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9753000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	13126000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	4298000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	4662000	usd
	us-gaap	Gross Profit GrossProfit	9387000	usd
	us-gaap	Gross Profit GrossProfit	8554000	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1229000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1147000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2365000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1854000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	377000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	418000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	743000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	659000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2595000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2562000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5493000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5422000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	797000	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	468000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1576000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1175000	usd
CY2023Q2	crex	Deal And Transaction Costs DealAndTransactionCosts	0	usd
CY2022Q2	crex	Deal And Transaction Costs DealAndTransactionCosts	37000	usd
	crex	Deal And Transaction Costs DealAndTransactionCosts	0	usd
	crex	Deal And Transaction Costs DealAndTransactionCosts	428000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	4998000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	4632000	usd
	us-gaap	Operating Expenses OperatingExpenses	10177000	usd
	us-gaap	Operating Expenses OperatingExpenses	9538000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-700000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	30000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-790000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-984000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	787000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	750000	usd
	us-gaap	Interest Expense InterestExpense	1590000	usd
	us-gaap	Interest Expense InterestExpense	1199000	usd
CY2023Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	16000	usd
CY2022Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	73000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	92000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	73000	usd
CY2023Q2	crex	Loss On Warrant Amendment LossOnWarrantAmendment	-0	usd
CY2022Q2	crex	Loss On Warrant Amendment LossOnWarrantAmendment	345000	usd
	crex	Loss On Warrant Amendment LossOnWarrantAmendment	-0	usd
	crex	Loss On Warrant Amendment LossOnWarrantAmendment	345000	usd
CY2023Q2	crex	Gain Loss On Settlement Of Debt GainLossOnSettlementOfDebt	0	usd
CY2022Q2	crex	Gain Loss On Settlement Of Debt GainLossOnSettlementOfDebt	21000	usd
	crex	Gain Loss On Settlement Of Debt GainLossOnSettlementOfDebt	0	usd
	crex	Gain Loss On Settlement Of Debt GainLossOnSettlementOfDebt	-274000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	123000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	135000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-680000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1285000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1547000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4804000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1380000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1315000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2337000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3820000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	45000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	53000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	88000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	56000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1425000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	1262000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2425000	usd
	us-gaap	Net Income Loss NetIncomeLoss	3764000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.62
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.62
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7406000
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7234000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7379000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6060000
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7406000
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7234000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7379000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6060000
	us-gaap	Net Income Loss NetIncomeLoss	-2425000	usd
	us-gaap	Net Income Loss NetIncomeLoss	3764000	usd
	crex	Depreciation Depletion And Amortization Excluding Amortization Of Debt Discount Premium DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtDiscountPremium	1576000	usd
	crex	Depreciation Depletion And Amortization Excluding Amortization Of Debt Discount Premium DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtDiscountPremium	1175000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	714000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	541000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	493000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1014000	usd
	crex	Loss On Warrant Amendment LossOnWarrantAmendment	0	usd
	crex	Loss On Warrant Amendment LossOnWarrantAmendment	345000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	274000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	309000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	106000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	92000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	73000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	46000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1458000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4035000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1119000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	562000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1035000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	811000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-585000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2487000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-559000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	229000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1604000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1178000	usd
	crex	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	1507000	usd
	crex	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	809000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	40000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-40000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6344000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-63000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-0	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	17186000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	219000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	32000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1984000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	2328000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2203000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19546000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	6000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	-0	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	1814000	usd
	crex	Proceeds From Warrant Issuance And Exercises ProceedsFromWarrantIssuanceAndExercises	0	usd
	crex	Proceeds From Warrant Issuance And Exercises ProceedsFromWarrantIssuanceAndExercises	8295000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	9868000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2510000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19566000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1631000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-43000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1633000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2883000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3264000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2840000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	25082000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1425000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	23858000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	25579000	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	139000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2425000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	23858000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	19060000	usd
CY2022Q2	crex	Adjustments To Additional Paid In Capital Amendment Of Warrants AdjustmentsToAdditionalPaidInCapitalAmendmentOfWarrants	5709000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	1262000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	26437000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8729000	usd
	crex	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	2278000	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	5000000	usd
	crex	Adjustments To Additional Paid In Capital Warrant Repricing AdjustmentsToAdditionalPaidInCapitalWarrantRepricing	0	usd
	crex	Adjustments To Additional Paid In Capital Amendment Of Warrants AdjustmentsToAdditionalPaidInCapitalAmendmentOfWarrants	5709000	usd
	us-gaap	Net Income Loss NetIncomeLoss	3764000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	26437000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	66666666
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-52834000	usd
CY2023Q2	crex	Working Capital WorkingCapital	6071000	usd
CY2023Q2	us-gaap	Debt Current DebtCurrent	4197000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-790000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6344000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	984000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	309000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	179000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1114000	usd
CY2023Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	551000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1671000	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	597000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	596000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	1148000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2267000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1895000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	1777000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7391651
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7490962
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i><em style="font: inherit;">10.</em> Use of Estimates</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Our significant estimates include: contingent purchase consideration valuation, allowance for credit losses, valuation allowances related to deferred taxes, the fair value of acquired assets and liabilities, the fair value of liabilities reliant upon the appraised fair value of the Company, valuation of stock-based compensation awards and other assumptions and estimates used to evaluate the recoverability of long-lived assets, goodwill and other intangible assets and the related amortization methods and periods. Actual results could differ from those estimates.</p>
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9196000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	10923000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	19140000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	21680000	usd
CY2021Q4	crex	Business Combination Contingent Consideration Billable Devices Online Maximum Share Price BusinessCombinationContingentConsiderationBillableDevicesOnlineMaximumSharePrice	21.60
CY2022Q4	crex	Business Combination Contingent Consideration Billable Devices Online Maximum Share Price BusinessCombinationContingentConsiderationBillableDevicesOnlineMaximumSharePrice	19.20
CY2022Q4	crex	Business Combination Contingent Consideration Billable Devices Online Reduction In Share Price BusinessCombinationContingentConsiderationBillableDevicesOnlineReductionInSharePrice	2.40
	crex	Conversion Of Liability Warrants To Equity Warrants ConversionOfLiabilityWarrantsToEquityWarrants	0	usd
	crex	Capitalized Software In Accounts Payable CapitalizedSoftwareInAccountsPayable	264000	usd
	crex	Capitalized Software In Accounts Payable CapitalizedSoftwareInAccountsPayable	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	23000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	89000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
	crex	Conversion Of Liability Warrants To Equity Warrants ConversionOfLiabilityWarrantsToEquityWarrants	5709000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1040000	usd
	us-gaap	Interest Paid Net InterestPaidNet	656000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	377000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	252000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	44000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	44000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	36843000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12907000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	35151000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11399000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12907000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11399000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	23936000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	23752000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	755000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	431000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1508000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1111000	usd
CY2023Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	18137000	usd
	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1731499
CY2023Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2355000	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	15782000	usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	4197000	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	11585000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	20641000	usd
CY2022	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1731499
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3069000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	17572000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	4499000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	13073000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	45000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	88000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	75000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	28000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y6M10D
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	65000	usd
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	30000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	55000	usd
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	45000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	70000	usd

Files In Submission

Name	View Source	Status
0001437749-23-022050-index-headers.html	Edgar Link	pending
0001437749-23-022050-index.html	Edgar Link	pending
0001437749-23-022050.txt	Edgar Link	pending
0001437749-23-022050-xbrl.zip	Edgar Link	pending
crex-20230630.xsd	Edgar Link	pending
crex20230630_10q.htm	Edgar Link	pending
crexlogonew.jpg	Edgar Link	pending
ex_527907.htm	Edgar Link	pending
ex_527908.htm	Edgar Link	pending
ex_527909.htm	Edgar Link	pending
ex_527910.htm	Edgar Link	pending
ex_553889.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
crex-20230630_pre.xml	Edgar Link	unprocessable
crex-20230630_lab.xml	Edgar Link	unprocessable
crex20230630_10q_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
crex-20230630_cal.xml	Edgar Link	unprocessable
crex-20230630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CREX
CREATIVE REALITIES, INC. Stock $crex

2023 Q3 Form 10-Q Financial Statement

#000143774923022050 Filed on August 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CREX CREATIVE REALITIES, INC. Stock $crex

2023 Q3 Form 10-Q Financial Statement

#000143774923022050 Filed on August 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CREX
CREATIVE REALITIES, INC. Stock $crex